3′-Azido-3′-deoxythymidine palmitate |
Trilaurin |
Stable after autoclaving, and can be lyophilized and rehydrated |
SLN |
[51] |
|
5-Fluorouracil |
Dynasa 114 and Dynasan 118 |
Prolonged release in simulated colonic medium |
SLN |
[52] |
|
Apomorphine |
Glyceryl monostearate, polyethylene glycol monostearate |
Enhanced the bioavailability in rats |
SLN |
[20] |
|
Ascorbyl palmitate |
Imwitor 900 and Labrafil M1944 |
Viscoelastic measurements is appropriate for topical/dermal application |
NLC |
[53] |
|
Baclofen |
Stearic acid |
Significantly higher drug concentrations in plasma |
SLN |
[54] |
|
Benzyl nicotinate |
Dynasan 116 |
Increased oxygenation in the skin |
SLN |
[55] |
|
Calcitonin |
Trimyristin |
Improvement of the efficiency of such carriers for oral delivery of proteins |
SLN |
[56] |
|
Camptothecin |
Monostearin and Soybean Oil 788 |
Stable and high performance delivery system |
NLC |
[57, 58] |
|
Clozapine |
Trimyristin, tripalmitin, and tristearin |
Improvement of bioavailability |
SLN |
[59] |
|
Cyclosporin A |
glyceryl monostearate, and glyceryl palmitostearate |
Controlled release |
SLN |
[60, 61] |
|
Dexamethasone |
Compritol 888 ATO |
Drug delivery topical use |
SLN |
[62] |
|
Diazepam |
Compritol ATO 888 and Imwitor 900 K |
Prolonged release |
SLN |
[63] |
|
Doxorubicin |
Glyceryl caprate |
Enhanced apoptotic death |
SLN |
[64] |
|
Gonadotropin release hormone |
Monostearin |
Prolonged release |
SLN |
[65] |
|
Hydrocortisone |
Monoglyceride, chain length of the fatty acid moiety |
SLN stable with release properties |
SLN |
[66] |
|
Ibuprofen |
stearic acid, triluarin, tripalmitin |
Stable formulation and negligible cell cytotoxicity |
SLN |
[67] |
|
Idarubicin |
Emulsifying wax |
Potential to deliver anticancer drugs |
SLN |
[68] |
|
Insulin |
Stearic acid, octadecyl alcohol, cetyl palmitate, glyceryl monostearate, glyceryl palmitostearate, glyceryl tripalmitate, glyceryl behenate |
Promising for oral delivery of proteins |
SLN |
[50] |
|
Ketoprofen |
mixture of beeswax and carnauba wax |
SLN with beeswax content exhibited faster drug release as compared carnauba wax |
SLN |
[69] |
|
Lopinavir |
Compritol 888 ATO |
Bioavailability enhanced |
SLN |
[70] |
|
Nimesulide |
Glyceryl behenate, palmitostearate, glyceryl tristearate |
Sustained drug release |
SLN |
[71] |
|
Penciclovir |
Glyceryl monostearate |
Provide a good skin targeting |
SLN |
[72] |
|
Progesterone |
Monostearin, stearic acid and oleic acid |
Potential drug delivery system for oral administration |
NLC |
[73, 74] |
|
Repaglinide |
Glycerol monostearate and tristearin |
Toxicity study indicated that the SLN were well tolerated |
SLN |
[22, 49] |
|
Salbutamol sulphate |
Monostearin and PEG2000 |
Formulation accelerate release of hydrophilic small molecule drugs |
SLN |
[75] |
|
Tetracycline |
glyceryl monostearate and stearic acid |
Sustained release |
SLN |
[76] |